Aaron Bloomer insider trades

Open-market stock purchases and sales by Aaron Bloomer, Chief Financial Officer at Resmed Inc, from SEC Form 4 filings since Feb 24, 2025.

Recent trades

DateStockTradeValue
Aug 14, 2026RMD Resmed IncBought (not open market)—
Mar 23, 2026EXAS Exact Sciences CorpBought (not open market)—
Mar 23, 2026EXAS Exact Sciences CorpSold (not open market)—
Mar 23, 2026EXAS Exact Sciences CorpSold (not open market)—
Mar 23, 2026EXAS Exact Sciences CorpSold (not open market)—
Mar 23, 2026EXAS Exact Sciences CorpSold (not open market)—
Feb 25, 2026EXAS Exact Sciences CorpBought (not open market)—
Dec 23, 2025EXAS Exact Sciences CorpSold (not open market)$1.1M
Dec 23, 2025EXAS Exact Sciences CorpBought (not open market)—
Dec 23, 2025EXAS Exact Sciences CorpBought (not open market)—
Dec 23, 2025EXAS Exact Sciences CorpSold (not open market)$1.7M

Companies traded

  • RMD Resmed Inc: other filings, last Aug 14, 2026
  • EXAS Exact Sciences Corp: other filings, last Mar 23, 2026

Get free alerts when Aaron Bloomer files a new trade →